Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2022-12-23
Buyer: SYKEHUSINNKJØP HF
Country: NO
Contract type: Supplies
Procedure: Contract award without prior publication
CPV classification: 33000000
Estimated value: 15915066 NOK
Award criteria: The most economic tender

Technical requirements: Lääketieteelliset laitteet, farmaseuttiset valmisteet ja henkilökohtaiseen hygieniaan liittyvät tuotteet
The Cancer Department will, thus, procure treatment planning licences for clinical use for proton treatment. In order to facilitate nationwide cooperation and ensure access to all necessary functions, the Cancer Department will purchase licenses for RaySearch. RaySearch is already in operation for research, and we would like to expand it with the clinical licences that are required for planning proton treatment. We have concluded that we must make a direct procurement of the system.
The procurement contract will include the purchase of three basic licenses for proton treatment planning, Citrix adaptation, installation, basic training, and individual licenses for extended functionality. The procurement contract includes an option for the necessary hardware, an option for extra training, and an option for service after expiry of the warranty.
The public procurement regulations, section 13-4 first paragraph letter b) no. 2 state that the contracting authority can make a procurement without a contest if the procurement concerns services that only a specific service provider can deliver as competition is impossible due to technical reasons.
Proton radiation is a new beam modality in Norway, and the centre that we are building is part of a national investment to extend the offer of proton radiotherapy to all cancer patients in Norway. For national cooperation, including cooperation regarding treatment protocols for trial patients among other things, it is paramount that we have access to the same TPS and licensed functionality as the Southern and Eastern Norway Regional Health Authority [Helse Sørøst (HSØ)], the Central Norway Regional Health Authority [Helse Midt (HM)] and the Northern Norway Regional Health Trust [Helse Nord (HN)].
The health trusts that are getting proton centres, including Bergen Hospital Trust, also have a responsibility for training for HM/HN (observation, courses), which means that Bergen Hospital Trust ought to have access to the same TPS for proton therapy as the other three health trusts.
RayStation has unique functionality which, for some patient cases, will be of significant import to the quality of the treatment plan. The procurement will make it possible to standardise proton treatment nationally while ensuring that proton treatment in Bergen and Oslo will be of the same quality.
Based on the above, a contest cannot be held for the delivery of the equipment that will be procured. This is due to technical reasons. The terms for making a procurement without a contest in accordance with the public procurement regulations, section 13-4, first section, letter b, no. 2 are therefore fulfilled.
The procurement contract includes an option for the necessary hardware, an option for extra training, and an option for service after expiry of the warranty.
Bergen Hospital Trust [Helse Bergen HF] will begin proton treatment for cancer patients in 2025. The Cancer Department will, thus, procure treatment planning licences for clinical use for proton treatment. In order to facilitate nationwide cooperation and ensure access to all necessary functions, the Cancer Department will purchase licenses for RaySearch. RaySearch is already in operation for research, and we would like to expand it with the clinical licences that are required for planning proton treatment. We have concluded that we must make a direct procurement of the system.
The procurement contract will include the purchase of three basic licenses for proton treatment planning, Citrix adaptation, installation, basic training, and individual licenses for extended functionality. The procurement contract includes an option for the necessary hardware, an option for extra training, and an option for service after expiry of the warranty.
The public procurement regulations, section 13-4 first paragraph letter b) no. 2 state that the contracting authority can make a procurement without a contest if the procurement concerns services that only a specific service provider can deliver as competition is impossible due to technical reasons.
Proton radiation is a new beam modality in Norway, and the centre that we are building is part of a national investment to extend the offer of proton radiotherapy to all cancer patients in Norway. For national cooperation, including cooperation regarding treatment protocols for trial patients among other things, it is paramount that we have access to the same TPS and licensed functionality as the Southern and Eastern Norway Regional Health Authority [Helse Sørøst (HSØ)], the Central Norway Regional Health Authority [Helse Midt (HM)] and the Northern Norway Regional Health Trust [Helse Nord (HN)].
The health trusts that are getting proton centres, including Bergen Hospital Trust, also have a responsibility for training for HM/HN (observation, courses), which means that Bergen Hospital Trust ought to have access to the same TPS for proton therapy as the other three health trusts.
RayStation has unique functionality which, for some patient cases, will be of significant import to the quality of the treatment plan. The procurement will make it possible to standardise proton treatment nationally while ensuring that proton treatment in Bergen and Oslo will be of the same quality.


Winner: RaySearch Laboratories AB
Award value: 15915066